Optimization of 131I activity value required for thyroid remnants and metastatic lesions ablation in children with differentiated thyroid cancer

被引:0
|
作者
Kozak, OV [1 ]
Shishkina, VV [1 ]
Korchinskaya, OL [1 ]
Sagan, DL [1 ]
Dzhuza, DA [1 ]
Trocevskiy, VV [1 ]
机构
[1] Ukraine Acad Med Sci, Inst Oncol, UA-03022 Kiev, Ukraine
关键词
thyroid cancer in children; I-131;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
66 children with differentiated thyroid cancer have been treated with I'll after thyroidectomy. Activities administered amounted from 370 to 5600 MBq. Patients were divided into three groups according to scintigraphy data: Group 1-with thyroid remnants only (25 patients), Group 2-with metastatic lesions in lymph nodes (15 patients), Group 3-with metastatic lesions in lungs (26 patients). The aim of the study was to evaluate parameters of radioiodine accumulation and excretion in remnants during radioiodine treatment in children after thyroidectomy, to determine the influence of I'll activity value on the result of the first course of radioiodine treatment. The fraction (f) of patients with thyroid remnants ablation after first course of the treatment within each specified activity range has been calculated and plotted against each interval of I-131 activity. In Group 3 number of courses required for total ablation of thyroid tissue was evaluated as a function of activities administered. In Group 1 f has a constant value (about 0.55) within the range of 1000-2500 MBq followed by the abrupt increase (up to 1) at 2500 MBq remaining at this plateau value with further increase of activity. In Group 3 number of courses of radioiodine treatment largely depends first activity value, namely the greater is first activity value the less is number of courses required for total ablation of remnants and metastatic lesions. The activity 2500 MBq could be considered as an optimal value for thyroid remnants ablation after first course of radioiodine treatment in children without metastatic lesions accumulating radioiodine, while in groups with metastatic lesions, for minimizing number of courses, first activity should be not less then 4000 MBq.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [21] Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients Dosimetry-based model for estimation
    Jentzen, W.
    Moldovan, A. -S.
    Ruhlmann, M.
    Goerges, R.
    Bockisch, A.
    Rosenbaum-Krumme, S.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 137 - 143
  • [22] Role of 131I in the treatment of well differentiated thyroid cancer
    Woodrum, DT
    Gauger, PG
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (03) : 114 - 121
  • [23] Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer
    Karls, Shawn
    Abikhzer, Gad
    Tamilia, Michael
    Probst, Stephan
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 247 - 249
  • [24] Radiodine uptake in thyroid remnants in patients with differentiated thyroid cancer:: A comparison between very-low 131I diagnostic dose and high 131I therapy activities
    Azevedo-Silva, F.
    Cavaco, A.
    Freitas, D.
    Isidoro, J.
    Vieira, F.
    Costa, G.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230
  • [25] Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer
    Luque-Ramirez, Manuel
    Gomez Ramirez, Joaquin
    Azcarate Villalon, Andrea
    Martin Perez, Elena
    Larranaga Barrera, Eduardo
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (07): : 412 - 414
  • [26] Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer
    Taylor, H
    Hyer, S
    Vini, L
    Pratt, B
    Cook, G
    Harmer, C
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (05) : 649 - 653
  • [27] Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) : 20N - 22N
  • [28] Iodine biokinetics and 131I absorbed dose in metastatic differentiated thyroid carcinoma
    Liu, Bin
    Kuang, Anren
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [29] A randomized study of the value of dosimetry in the use of 131I for ablation of post. operative thyroid remnants.
    Silberstein, EB
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 350P - 350P
  • [30] Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature
    Xue, Yan-Li
    Qiu, Zhong-Ling
    Song, Hong-Jun
    Luo, Quan-Yong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) : 768 - 778